The modulation of retinol and lipid binding proteins to enhance cell death in Ewing's Sarcoma Family of Tumours
There have been few advances in treatment for patients with tumours belonging to the Ewing’s Sarcoma Family of Tumours (ESFT) in the past three decades. Currently just 1 in 5 young people with metastatic disease survive to 5 years, and 1 in 10 who appear to do well initially, face the grim prospect...
Main Author: | Arasu, Shireen Niala Gopaul |
---|---|
Other Authors: | Burchill, Susan ; Elliott, Martin ; Fishwick, Colin |
Published: |
University of Leeds
2017
|
Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.745543 |
Similar Items
-
Fenretinide-induced cell death in Ewing's sarcoma family of tumours
by: Myatt, Stephen Samuel
Published: (2006) -
Wnt signalling in the Ewing's sarcoma family of tumours
by: Shaw, Lucy Abigail
Published: (2014) -
International randomised controlled trial for the treatment of newly diagnosed EWING sarcoma family of tumours – EURO EWING 2012 Protocol
by: Jennifer Anderton, et al.
Published: (2020-01-01) -
Blue Cell Tumour at Unusual Site: Retropritoneal Ewings Sarcoma
by: Anita P Javalgi, et al.
Published: (2016-04-01) -
Proliferation index: a continuous model to predict prognosis in patients with tumours of the Ewing's sarcoma family.
by: Samantha Brownhill, et al.
Published: (2014-01-01)